CalciMedica, Inc. Files 8-K with Corporate Updates
Ticker: CALC · Form: 8-K · Filed: Oct 30, 2024 · CIK: 1534133
| Field | Detail |
|---|---|
| Company | Calcimedica, INC. (CALC) |
| Form Type | 8-K |
| Filed Date | Oct 30, 2024 |
| Risk Level | low |
| Pages | 6 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, company-information
TL;DR
CalciMedica filed an 8-K on 10/30/24 detailing corporate info and past name changes.
AI Summary
CalciMedica, Inc. filed an 8-K on October 30, 2024, reporting on various events. The filing includes information about the company's incorporation in Delaware, its IRS number, and its business address in La Jolla, California. It also lists former company names and dates of name changes, indicating a history of corporate evolution.
Why It Matters
This 8-K filing provides essential corporate information and historical context for CalciMedica, Inc., which is important for investors and stakeholders to understand the company's structure and evolution.
Risk Assessment
Risk Level: low — The filing is primarily informational, detailing corporate structure and history without announcing significant new risks or financial events.
Key Numbers
- 001-39538 — SEC File Number (Identifies the company's filing with the SEC)
- 45-2120079 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- CalciMedica, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- La Jolla, California (location) — Business address
- GRAYBUG VISION, INC. (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for CalciMedica, Inc.?
The primary purpose is to report current information as required by the SEC, including details about the company's incorporation, IRS number, business address, and former company names.
When was CalciMedica, Inc. incorporated, and in which jurisdiction?
CalciMedica, Inc. was incorporated in Delaware, as indicated by the filing.
What is the business address of CalciMedica, Inc.?
The business address is 505 Coast Boulevard South, Suite 307, La Jolla, California.
Has CalciMedica, Inc. operated under different names in the past?
Yes, the filing indicates previous names including GRAYBUG VISION, INC. and GRAYBUG, Inc., with specific dates of name changes.
What is the SEC file number for CalciMedica, Inc.?
The SEC file number for CalciMedica, Inc. is 001-39538.
Filing Stats: 1,902 words · 8 min read · ~6 pages · Grade level 12.7 · Accepted 2024-10-30 07:24:04
Key Financial Figures
- $0 — nge on which registered Common Stock, $0.0001, par value per share CALC The
Filing Documents
- d885957d8k.htm (8-K) — 39KB
- d885957dex991.htm (EX-99.1) — 26KB
- d885957dex992.htm (EX-99.2) — 39KB
- g885957ex99_2p10g1.jpg (GRAPHIC) — 72KB
- g885957ex99_2p11g1.jpg (GRAPHIC) — 281KB
- g885957ex99_2p12g1.jpg (GRAPHIC) — 324KB
- g885957ex99_2p13g1.jpg (GRAPHIC) — 320KB
- g885957ex99_2p14g1.jpg (GRAPHIC) — 213KB
- g885957ex99_2p15g1.jpg (GRAPHIC) — 294KB
- g885957ex99_2p16g1.jpg (GRAPHIC) — 229KB
- g885957ex99_2p17g1.jpg (GRAPHIC) — 313KB
- g885957ex99_2p18g1.jpg (GRAPHIC) — 366KB
- g885957ex99_2p19g1.jpg (GRAPHIC) — 328KB
- g885957ex99_2p1g1.jpg (GRAPHIC) — 365KB
- g885957ex99_2p20g1.jpg (GRAPHIC) — 339KB
- g885957ex99_2p21g1.jpg (GRAPHIC) — 318KB
- g885957ex99_2p22g1.jpg (GRAPHIC) — 289KB
- g885957ex99_2p23g1.jpg (GRAPHIC) — 110KB
- g885957ex99_2p24g1.jpg (GRAPHIC) — 320KB
- g885957ex99_2p25g1.jpg (GRAPHIC) — 323KB
- g885957ex99_2p26g1.jpg (GRAPHIC) — 285KB
- g885957ex99_2p27g1.jpg (GRAPHIC) — 74KB
- g885957ex99_2p28g1.jpg (GRAPHIC) — 270KB
- g885957ex99_2p29g1.jpg (GRAPHIC) — 163KB
- g885957ex99_2p2g1.jpg (GRAPHIC) — 540KB
- g885957ex99_2p30g1.jpg (GRAPHIC) — 229KB
- g885957ex99_2p31g1.jpg (GRAPHIC) — 249KB
- g885957ex99_2p32g1.jpg (GRAPHIC) — 154KB
- g885957ex99_2p33g1.jpg (GRAPHIC) — 93KB
- g885957ex99_2p34g1.jpg (GRAPHIC) — 210KB
- g885957ex99_2p35g1.jpg (GRAPHIC) — 87KB
- g885957ex99_2p36g1.jpg (GRAPHIC) — 293KB
- g885957ex99_2p37g1.jpg (GRAPHIC) — 87KB
- g885957ex99_2p38g1.jpg (GRAPHIC) — 230KB
- g885957ex99_2p3g1.jpg (GRAPHIC) — 243KB
- g885957ex99_2p4g1.jpg (GRAPHIC) — 211KB
- g885957ex99_2p5g1.jpg (GRAPHIC) — 275KB
- g885957ex99_2p6g1.jpg (GRAPHIC) — 230KB
- g885957ex99_2p7g1.jpg (GRAPHIC) — 353KB
- g885957ex99_2p8g1.jpg (GRAPHIC) — 242KB
- g885957ex99_2p9g1.jpg (GRAPHIC) — 321KB
- g885957g1030043001009.jpg (GRAPHIC) — 5KB
- 0001193125-24-247004.txt ( ) — 13551KB
- calc-20241030.xsd (EX-101.SCH) — 3KB
- calc-20241030_lab.xml (EX-101.LAB) — 18KB
- calc-20241030_pre.xml (EX-101.PRE) — 11KB
- d885957d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits. (d) Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated October 30, 2024. 99.2 Slide presentation titled "Developing Novel Therapies for Acute Inflammatory and Immunologic Diseases" dated October 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CalciMedica, Inc. Date: October 30, 2024 By: /s/ A. Rachel Leheny, Ph.D. Name: A. Rachel Leheny, Ph.D. Title: Chief Executive Officer